0001209191-14-051234.txt : 20140807 0001209191-14-051234.hdr.sgml : 20140807 20140807180254 ACCESSION NUMBER: 0001209191-14-051234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140805 FILED AS OF DATE: 20140807 DATE AS OF CHANGE: 20140807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ueno Ryuji CENTRAL INDEX KEY: 0001384370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 141025108 MAIL ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY STREET 2: SUITE 300 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-08-05 0 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001384370 Ueno Ryuji 4520 EAST-WEST HIGHWAY SUITE 300 BETHESDA MD 20814 0 0 1 0 Class A Common Stock 2014-08-05 4 S 0 84243 6.2408 D 22558286 I By S&R Technology Holdings, LLC Class A Common Stock 2014-08-06 4 S 0 30523 6.3231 D 22527763 I By S&R Technology Holdings, LLC Class A Common Stock 2014-08-07 4 S 0 66961 6.3148 D 22460802 I By S&R Technology Holdings, LLC Class A Common Stock 353530 D Class A Common Stock 60357 I By Wife The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by S&R Technology Holdings, LLC on September 11, 2013. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.13 to $6.37, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.02 to $6.41, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.46, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Dr. Ueno disclaims beneficial ownership of the reported securities. /s/ Kei Tolliver, by Power of Attorney 2014-08-07